Drugs / G-CSF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06520176 | Aug 2024 → Dec 2026 expected | hemopoietic proliferation, plasma cell myeloma | The Affiliated People's Hospital of Ningbo University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06520176 ↗ |
| Route | Subcutaneous | “Subcutaneous injection at dose 5ug/kg, from day 6 until the end of mobilization.” NCT06520176 ↗ |